IRIS
TONINI, GIUSEPPE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 18.639
NA - Nord America 4.093
EU - Europa 1.847
SA - Sud America 145
AF - Africa 75
OC - Oceania 58
AN - Antartide 2
Continente sconosciuto - Info sul continente non disponibili 2
Totale 24.861
Salva come PNG Salva come JPEG
Nazione #
SG - Singapore 13.962
US - Stati Uniti d'America 3.890
HK - Hong Kong 2.230
CN - Cina 2.050
GB - Regno Unito 630
IT - Italia 371
DE - Germania 270
IN - India 139
CA - Canada 133
BR - Brasile 103
NL - Olanda 101
FI - Finlandia 78
MX - Messico 55
VN - Vietnam 54
ZA - Sudafrica 54
AU - Australia 53
JP - Giappone 49
TR - Turchia 49
ES - Italia 47
PL - Polonia 44
UA - Ucraina 41
FR - Francia 39
CZ - Repubblica Ceca 36
SE - Svezia 26
EE - Estonia 24
CH - Svizzera 20
ID - Indonesia 19
LT - Lituania 17
BE - Belgio 15
BG - Bulgaria 15
AR - Argentina 13
KR - Corea 13
AT - Austria 12
BD - Bangladesh 12
RU - Federazione Russa 9
IL - Israele 8
PE - Perù 8
RO - Romania 8
TW - Taiwan 8
HU - Ungheria 6
SA - Arabia Saudita 6
CL - Cile 5
PH - Filippine 5
PT - Portogallo 5
BA - Bosnia-Erzegovina 4
DM - Dominica 4
EG - Egitto 4
IE - Irlanda 4
SI - Slovenia 4
SK - Slovacchia (Repubblica Slovacca) 4
TH - Thailandia 4
AL - Albania 3
BY - Bielorussia 3
DO - Repubblica Dominicana 3
EC - Ecuador 3
NO - Norvegia 3
PY - Paraguay 3
TN - Tunisia 3
UY - Uruguay 3
UZ - Uzbekistan 3
AE - Emirati Arabi Uniti 2
AQ - Antartide 2
AZ - Azerbaigian 2
CO - Colombia 2
CY - Cipro 2
FK - Isole Falkland (Malvinas) 2
GR - Grecia 2
IQ - Iraq 2
IR - Iran 2
JO - Giordania 2
KW - Kuwait 2
KZ - Kazakistan 2
LU - Lussemburgo 2
NZ - Nuova Zelanda 2
PR - Porto Rico 2
TO - Tonga 2
VE - Venezuela 2
AM - Armenia 1
AO - Angola 1
BF - Burkina Faso 1
BO - Bolivia 1
CI - Costa d'Avorio 1
CU - Cuba 1
CV - Capo Verde 1
CW - ???statistics.table.value.countryCode.CW??? 1
DK - Danimarca 1
DZ - Algeria 1
GA - Gabon 1
GT - Guatemala 1
HR - Croazia 1
JM - Giamaica 1
KG - Kirghizistan 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LV - Lettonia 1
MG - Madagascar 1
ML - Mali 1
MS - Montserrat 1
MY - Malesia 1
NE - Niger 1
Totale 24.844
Salva come PNG Salva come JPEG
Città #
Hong Kong 2.215
Hefei 1.202
Singapore 1.155
Ashburn 923
Boardman 700
London 555
Shanghai 405
Dallas 294
Beijing 234
Los Angeles 150
San Francisco 138
Munich 134
Council Bluffs 128
Pune 84
Seattle 84
Toronto 77
Rome 71
Santa Clara 66
New York 63
Amsterdam 62
Washington 62
Turku 46
Warsaw 43
São Paulo 40
Mexico City 39
Tokyo 38
Brno 34
Johannesburg 33
Brooklyn 32
Helsinki 31
Montreal 31
Chicago 30
Melbourne 30
Chennai 24
Ho Chi Minh City 24
Boston 22
Milan 22
Naples 22
Stockholm 22
Atlanta 16
Phoenix 16
Secaucus 16
West Jordan 14
Burgas 13
Hanover 13
Ankara 12
Canberra 12
Charlotte 12
Denver 12
Hasselt 12
Manchester 12
St Louis 12
Poplar 11
Sydney 11
Padova 10
Sona 10
Guangzhou 9
Hanoi 9
The Dalles 9
Central 8
Haikou 8
Las Vegas 8
Redmond 8
San Jose 8
Buffalo 7
Campobasso 7
New Delhi 7
Oklahoma City 7
Vienna 7
Xi'an 7
Baoding 6
Boydton 6
Honolulu 6
Madrid 6
Mumbai 6
Palermo 6
Paris 6
Shijiazhuang 6
Andover 5
Charleston 5
Cleveland 5
Haifa 5
Lima 5
Modena 5
New Taipei 5
Riyadh 5
Salt Lake City 5
San Pietro in Lama 5
Teramo 5
Topeka 5
Yeonsu-gu 5
Bangkok 4
Cincinnati 4
Dublin 4
Florence 4
Frankfurt am Main 4
Istanbul 4
Lincoln 4
Liverpool 4
Markham 4
Totale 9.837
Salva come PNG Salva come JPEG
Nome #
A new dose-intense epoetin alfa regimen effective in anemic cancer patients receiving chemotherapy: An open-label, non randomized, pilot study 224
1065P Dose dependent detrimental effect of baseline pantoprazole on clinical outcomes from first-line chemo-ICI regimens in patients with advanced stage NSCLC 214
A novel predictive biomarker of immunotherapy response in metastatic renal cell carcinoma (mRCC): The lymphocyte microRNA expression profile. 214
Bisphosphonates as anticancer agents in early breast cancer: preclinical and clinical evidence 207
A hitherto unreported high incidence of zoledronic acid-induced acute phase reaction in patients with cancer treatment-induced bone loss 206
5-Fluorouracil, epirubicin, and BCNU (FEB) in advanced measurable gastric cancer 206
COX-2 expression in ampullary carcinoma: correlation with angiogenesis process and clinicopathological variables 205
ANGIOGENESIS AND ONCOGENES IN COLON CANCER 204
Clinical implications of the family history in patients with lung cancer: a systematic review of the literature and a new cross-sectional/prospective study design (FAHIC: lung) 203
Biological Effects of Cyclin-Dependent Kinase Inhibitors Ribociclib, Palbociclib and Abemaciclib on Breast Cancer Bone Microenvironment 201
Early impairment of food intake in patients newly diagnosed with cancer 201
Chondrosarcoma of the iliac wing in Von Hippel-Lindau disease 199
Expression pattern of receptor activator of NFκB (RANK) in a series of primary solid tumors and related bone metastases 199
Complementary use of local excision and transanal endoscopic microsurgery for rectal cancer after neoadjuvant chemoradiation 198
96P Induction chemotherapy backbone in frail patients (pts) with advanced NSCLC treated with chemotherapy plus pembrolizumab (P): A single institution retrospective audit of dose intensities from modified regimens 197
A new bioinformatic pipeline allows the design of small, targeted gene panels for efficient TMB estimation 197
S-Adenosylmethionine (AdoMet) supplementation for treatment of chemotherapy-induced liver injury 196
Cyclooxygenase-2 overexpression is associated with a poor outcome in resected ampullary cancer patients 195
Artificial Intelligence in Detection, Management, and Prognosis of Bone Metastasis: A Systematic Review 194
In Situ Identification of CD44+/CD24− cancer cells in primary human breast carcinomas 193
Premetastatic niche: ready for new therapeutic interventions? 192
COX-2 expression in DCIS: correlation with VEGF, HER-2/neu, prognostic molecular markers and clinicopathological features 192
Bone metastases in breast cancer: higher prevalence of osteosclerotic lesions 192
A phase 2 study of temozolomide in pretreated metastatic colorectal cancer with MGMT promoter methylation 191
COX-2 expression in lobular in situ neoplasia of the breast: correlation with histopathological grading system according to the Tavassoli classification 191
Bevacizumab in association with de Gramont 5-fluorouracil/folinic acid in patients with oxaliplatin-, irinotecan-, and cetuximab-refractory colorectal cancer: a single-center phase 2 trial 188
Enoxiparin effects depend on body-weight and current doses my be inadequate in obese patients 185
[Methodological issues and first results of a record linkage between AIDS and Cancer Registries in Italy 183
Prevention of radiotherapy-induced emesis 183
COX-2 expression of ampullary carcinoma: correlation with different histotypes and clinicopathological parameters 181
Association between NOD2/CARD15 polymorphisms and coronary artery disease: a case-control study 181
Bisphosphonates: new antiangiogenic molecules in cancer treatment? 181
Alternative dosing schedules for sunitinib as a treatment of patients with metastatic renal cell carcinoma 181
Early opioid exposure (EOE) and impaired efficacy in patients with advanced NSCLC treated with PD-L1 inhibition: A pooled post hoc analysis of the POPLAR and OAK trials 180
Zoledronic acid-related angiogenesis modifications and survival in advanced breast cancer patients 180
Complications of therapy in cancer patients: Case 3. Toxic epidermal necrolysis induced by oral phenobarbital and whole-brain radiotherapy in a breast cancer patient 175
Zoledronic acid induces significant and long-lasting modifications of circulating angiogenic factors in cancer patients 175
Gemcitabine-induced atrial fibrillation: A hitherto unreported manifestation of drug toxicity 171
NOD2/CARD15 polymorphisms impair innate immunity and increase susceptibility to gastric cancer in an Italian population 170
A staphylococcus aureus coinfection on a COVID-19 pneumonia in a breast cancer patient 169
Neoadjuvant concurrent radiochemotherapy in locally advanced (IIIA-IIIB) non-small-cell lung cancer: long-term results according to downstaging 167
Body mass index and impaired fasting blood glucose as predictive factor of time to progression (TTP) in cetuximab-based colorectal cancer treatment 167
Bisphosphonate effects in cancer and inflammatory diseases: in vitro and in vivo modulation of cytokine activities 166
Docetaxel induced pericardial effusion 162
Longitudinal evaluation of vitamin D plasma levels during anthracycline- and docetaxel-based adjuvant chemotherapy in early-stage breast cancer patients 154
Angiogenesis modifications related with cetuximab plus irinotecan as anticancer treatment in advanced colorectal cancer patients 140
BOMB trial: First results of stereotactic radiotherapy to primary breast tumor in metastatic breast cancer patients 121
Anti-EGFR Therapy in Metastatic Small Bowel Adenocarcinoma: Myth or Reality? 115
A giant sarcoma of the parotid gland: A case report and review of the literature 114
'Internal bracing' surgery in the management of solid tumor metastases of the thoracic and lumbar spine 110
'All action no talk': the role of HER2/neu in adjuvant therapy choice for gastric cancer 108
Concurrent Use of Abemaciclib and Radiotherapy in Metastatic Breast Cancer Patients: A Single-Center Experience 107
Prospective observational multicentric case-control study about 'fatigue' in patients with history of breast cancer 106
Early magnesium reduction in advanced colorectal cancer patients treated with cetuximab plus irinotecan as predictive factor of efficacy and outcome 106
Bilateral irreversible hearing loss associated with the combination of carboplatin and paclitaxel chemotherapy: a unusual side effect 103
A prospective analysis of CT density measurements of bone metastases after treatment with zoledronic acid 102
Colorectal carcinomas and PTEN/MMAC1 gene mutations 101
Concurrent radiotherapy with palbociclib or ribociclib for metastatic breast cancer patients: preliminary assessment of toxicity 100
A close relationship between HIF-1α expression and bone metastases in advanced NSCLC, a retrospective analysis 100
'Old' and 'new' drugs for the treatment of cancer pain 100
Pancreatitis after percutaneous ethanol injection into HCC: a minireview of the literature 98
Carcinoma of the Ampulla of Vater morphological and immunophenotypical classification predicts overall survival 96
Body Mass Index as a Risk Factor for Toxicities in Patients with Advanced Soft-Tissue Sarcoma Treated with Trabectedin 95
[Neoplastic hypercalcemia]. 94
A Phase II Trial of Fixed-Dose Rate Gemcitabine plus Capecitabine in Metastatic/Advanced Biliary Tract Cancer Patients 94
A phase II study of weekly cisplatin, 6S-stereoisomer leucovorin and fluorouracil as first-line chemotherapy for elderly patients with advanced gastric cancer 93
A pathology-based combined model to identify pam50 non-luminal intrinsic disease in hormone receptor-positive HER2-negative breast cancer 93
How I Treat Localized Soft Tissue Sarcomas: Update on Diagnosis, Risk Stratification, and Treatment 92
Atypical case of metastatic undifferentiated prostate carcinoma in a 36 years old man: clinical report and literature review 92
Biological effects of cabozantinib on bone microenvironment 92
An increase of CA 19.9 as the first clinical sign of ileocecal valve metastasis from breast cancer 91
Cerebellar metastasis from pancreatic adenocarcinoma. A case report 91
Changes in bone resorption and vascular endothelial growth factor after a single zoledronic acid infusion in cancer patients with bone metastases from solid tumours 91
Abstract P5-04-13: Antibody-based therapy targeting integrin a5 is an effective strategy to treat experimental breast cancer bone metastasis 91
Stereotactic Radiation and Dual Human Epidermal Growth Factor Receptor 2 Blockade with Trastuzumab and Pertuzumab in the Treatment of Breast Cancer Brain Metastases: A Single Institution Series 91
A form to report pain assessment and monitoring in the oncology clinical record: a Delphi process 90
Serum VEGF levels as predictive marker of bisphosphonate-related osteonecrosis of the jaw 90
Continuous infusion of oxaliplatin plus chronomodulated capecitabine in 5-fluorouracil- and irinotecan-resistant advanced colorectal cancer patients 90
Cetuximab and irinotecan as third-line therapy in advanced colorectal cancer patients: a single centre phase II trial 90
Biological and clinical effects of abiraterone on anti-resorptive and anabolic activity in bone microenvironment 90
Azygo-tracheal fistula in a complete implantable central venous system 90
Brain microischemic phenomena in a woman receiving bevacizumab treatment: a case report 90
Biological effects of cabozantinib on osteosarcoma-bone microenvironment model 90
Idiosyncratic reaction after oxaliplatin infusion 89
Cabozantinib targets bone microenvironment modulating human osteoclast and osteoblast functions 89
Body Mass Index and Impaired Fasting Blood Glucose as Predictive Factors of Efficacy in Cetuximab-Based Colorectal Cancer Treatment 89
Changes in bone turnover markers in patients without bone metastases receiving immune checkpoint inhibitors: An exploratory analysis 88
In vivo effects of zoledronic acid on peripheral gamma delta T lymphocytes in early breast cancer patients 88
Liver cirrhosis after prolonged therapy with IFN-alpha plus interleukin-2 in a metastatic renal cancer long-term survivor 88
[Aztreonam and oxacillin in the treatment of febrile neutropenic patients with solid tumors]. 88
Liver involvement in the course of thymoma-associated multiorgan autoimmunity: The first histological description 88
An omental mass: any hypothesis? 87
Zoledronic acid induces a significant decrease of circulating endothelial cells and circulating endothelial precursor cells in the early prostate cancer neoadjuvant setting. 87
Circulating VEGF reduction, response and outcome in advanced colorectal cancer patients treated with cetuximab plus irinotecan 87
Atypical chronic head and neck pain: don't forget Eagle's syndrome 87
A Longitudinal Study of Breakthrough Cancer Pain: An Extension of IOPS-MS Study 87
Long non-coding RNA HSAT II as a new biomarker for the identification of high risk intraductal papillary mucinous neoplasms (IPMNs). 86
Cox-2 Expression in Different Histotypes of Ampullary Carcinoma 86
Apoptotic index or a combination of Bax/Bcl-2 expression correlate with survival after resection of pancreatic adenocarcinoma 86
Antitumor effect of cabozantinib in bone metastatic models of renal cell carcinoma 85
Totale 13.742
Salva come PNG Salva come JPEG
Categoria #
all - tutte 236.091
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 236.091
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022839 0 5 8 11 63 5 6 5 20 22 19 675
2022/2023202 22 7 3 19 9 8 18 18 12 1 76 9
2023/20242.026 46 228 137 146 186 872 21 131 26 67 78 88
2024/202519.040 311 224 781 138 150 472 324 79 1.660 1.529 6.204 7.168
2025/20262.903 1.669 739 495 0 0 0 0 0 0 0 0 0
Totale 25.010